Sydney Lupkin

5 things we found in the FDA’s hidden device database Sydney Lupkin

Consumers rejected drug plan that mirrors Trump administration proposal Sydney Lupkin

Trump administration salutes parade of generic drug approvals, but hundreds aren’t for sale Sydney Lupkin

Pfizer settles kickback case related to copay assistance for $24M Sydney Lupkin

Drugmakers blamed for blocking generics have jacked up prices Sydney Lupkin

Patients overpay for prescriptions 23% of the time, analysis shows Sydney Lupkin

Drugmakers dramatically boosted lobbying spending in Trump’s first quarter Sydney Lupkin

Page: 1